-
EP1333036
European procedure
Extract from the Register of European Patents
EP Citations: EP1333036
| Cited in | Search | Type: | Patent literature | Publication No.: | WO0032772
[XY] (LILLY CO ELI et al.) [X] 1,3-8 * page 6 - page 7 * * page 12 * * page 17 - page 18; figure 8; example 1q; claims 6,31; tables II,IV * * page 43, line 6 - line 25 *[Y] 2 | Type: | Patent literature | Publication No.: | EP0605963
[X] (ORTHO PHARMA CORP et al.) [X] 1,4,5 * page 11, paragraph 1; claims 5,6,10-12 * * page 12, paragraph 4 - paragraph 5 * | Type: | Patent literature | Publication No.: | WO9903887
[X] (BOLDER BIOTECHNOLOGY INC et al.) [X] 1,4 * example 2; claims 1,5,8 * | Type: | Patent literature | Publication No.: | WO0042175
[A] (BOLDER BIOTECHNOLOGY INC et al.) [A] 1-8 * page 6 * * page 45 * | Type: | Patent literature | Publication No.: | US4904584
[A] (SHAW GRAY et al.) [A] 1-8 * the whole document * | Type: | Patent literature | Publication No.: | US4179337
[A] (DAVIS FRANK F et al.) [A] 1-8 * the whole document * | Type: | Patent literature | Publication No.: | WO9832466
[A] (POLYMASC PHARMACEUTICALS PLC et al.) [A] 1-8 * examples 7,8 * | Type: | Patent literature | Publication No.: | US5824784
[A] (KINSTLER OLAF B et al.) [A] 1-8 * column 3, paragraph 4 * * column 7, paragraph 4 * * column 9, paragraph 2 * | Type: | Patent literature | Publication No.: | WO0102017
[PA] (HOFFMANN LA ROCHE et al.) [PA] 1-8 * page 15 * * page 26 * | Type: | Non-patent literature | Publication information: | [Y] MONKARSH SP ET AL: "Positional isomers of monopegylated interferon alpha-2a: isolation, characterization, and biological activity", ANALYTICAL BIOCHEMISTRY, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 247, no. 2, 1 May 1997 (1997-05-01), pages 434 - 440, XP002092303, ISSN: 0003-2697 [Y] 2 * the whole document * | DOI: | http://dx.doi.org/10.1006/abio.1997.2128 | Type: | Non-patent literature | Publication information: | [A] FRANCIS G E ET AL: "PEGYLATION OF CYTOKINES AND OTHER THERAPEUTIC PROTEINS AND PEPTIDES: THE IMPORTANCE OF BIOLOGICAL OPTIMISATION OF COUPLING TECHNIQUES", INTERNATIONAL JOURNAL OF HEMATOLOGY, ELSEVIER SCIENCE PUBLISHERS, NL, vol. 68, no. 1, July 1998 (1998-07-01), pages 1 - 18, XP000791226, ISSN: 0925-5710 [A] 1-8 * page 10, column R * | DOI: | http://dx.doi.org/10.1016/S0925-5710(98)00039-5 | Type: | Non-patent literature | Publication information: | [A] MALIK F ET AL: "PEG-MODIFIED ERYTHROPOIETIN WITH IMPROVED EFFICACY", EXPERIMENTAL HEMATOLOGY, NEW YORK, NY, US, vol. 28, no. 7, July 2000 (2000-07-01), pages 106, XP001060375, ISSN: 0301-472X [A] 1-8 * the whole document * | DOI: | http://dx.doi.org/10.1016/S0301-472X(00)00416-1 | Type: | Non-patent literature | Publication information: | [A] MALIK F ET AL: "POLYETHYLENE GLYCOL (PEG) MODIFIED ERYTHROPOIETIN: A SECOND GENERATION CYTOKINE", EXPERIMENTAL HEMATOLOGY, NEW YORK, NY, US, vol. 23, no. 8, August 1995 (1995-08-01), pages 835, XP001106915, ISSN: 0301-472X [A] 1-8 * the whole document * | Cited in | Examination | Type: | Patent literature | Publication No.: | EP1064951
| Cited in | by applicant | Type: | Non-patent literature | Publication information: | "Polyethylene glycol-conjugated pharmaceutical proteins", PSTT, vol. 1, no. 8, 1998, pages 352 - 356 |